Results: The total efficiency of the joint use of rabeprazole and mosapride in treating reflux esophagitis is 95.24%, it is significantly higher than that of famotidine Lactulose, and has fe...

• 结果:雷贝拉唑联合莫沙必利组治疗反流性食管炎总有效率为95.；24%25；疗效显著高于法莫替丁联合莫沙必利组；且不良反应少。结论:雷贝拉唑联合莫沙必利治疗反流性食管炎疗效明显；安全可靠。